AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2014
Jul 1, 2014
34931_dirs_2014-07-01_9dac1247-f6d4-40b7-8e8d-eaf7e985e55c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-06-30
Reporting Person: LOSORDO DOUGLAS W (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-30 | Common stock, par value $0.001 per share | A | 1736 | $5.542 | Acquired | 23736 | Direct |
Footnotes
F1: Shares purchased pursuant to NeoStem, Inc.'s 2012 Employee Stock Purchase Plan for the period ended June 30, 2014